Vanda Pharmaceuticals (VNDA) Q3 2025 Earnings

31JulConfirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-0.57
-0.41
-0.24
-0.08

Details

Expected EPS
-0.356667
Actual EPS
-0.46
Surprise EPS
-0.1
Surprise Percent
+28.97%

Description

Vanda Pharmaceuticals (VNDA) has reported earnings of -0.46 per share for Q3 2025.

0 Comments

Share your thoughts